Ovarian Cancer
Ovarian Cancer: Recommendations and Genomic Insights - April 1, 2015
Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v3cIWXmdKNZcprEpZcaRt3r76_tygEW3QcbjbyD96VNB-BWM-jt6903EobvLmlakeCVbdPZqCtYhroAj5NPxafr5LZh4Iv84T2UT3ZbfaaCDhYoJeNeqjC=s0-d)
Walker J L et al. Cancer2015 Mar 27.
Walker J L et al. Cancer2015 Mar 27.
New insights in the pathophysiology of ovarian cancer and implications for screening and prevention.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v3cIWXmdKNZcprEpZcaRt3r76_tygEW3QcbjbyD96VNB-BWM-jt6903EobvLmlakeCVbdPZqCtYhroAj5NPxafr5LZh4Iv84T2UT3ZbfaaCDhYoJeNeqjC=s0-d)
Nezhat FR et al. Am. J. Obstet. Gynecol. 2015 Mar 25.
Nezhat FR et al. Am. J. Obstet. Gynecol. 2015 Mar 25.
Immunotherapeutic approaches to ovarian cancer treatment.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v3cIWXmdKNZcprEpZcaRt3r76_tygEW3QcbjbyD96VNB-BWM-jt6903EobvLmlakeCVbdPZqCtYhroAj5NPxafr5LZh4Iv84T2UT3ZbfaaCDhYoJeNeqjC=s0-d)
Chester C et al. J Immunother Cancer 2015 7
Chester C et al. J Immunother Cancer 2015 7
Two decades beyond BRCA1/2: Homologous recombination, hereditary cancer risk and a target for ovarian cancer therapy.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v3cIWXmdKNZcprEpZcaRt3r76_tygEW3QcbjbyD96VNB-BWM-jt6903EobvLmlakeCVbdPZqCtYhroAj5NPxafr5LZh4Iv84T2UT3ZbfaaCDhYoJeNeqjC=s0-d)
Walsh CS et al. Gynecol. Oncol. 2015 Feb 25.
Walsh CS et al. Gynecol. Oncol. 2015 Feb 25.
Identification of susceptibility genes for peritoneal, ovarian, and deep infiltrating endometriosis using a pooled sample-based genome-wide association study.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v3cIWXmdKNZcprEpZcaRt3r76_tygEW3QcbjbyD96VNB-BWM-jt6903EobvLmlakeCVbdPZqCtYhroAj5NPxafr5LZh4Iv84T2UT3ZbfaaCDhYoJeNeqjC=s0-d)
Borghese B et al. Biomed Res Int 2015 461024
Borghese B et al. Biomed Res Int 2015 461024
New insights into tumor immunity revealed by the unique genetic and genomic aspects of ovarian cancer.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v3cIWXmdKNZcprEpZcaRt3r76_tygEW3QcbjbyD96VNB-BWM-jt6903EobvLmlakeCVbdPZqCtYhroAj5NPxafr5LZh4Iv84T2UT3ZbfaaCDhYoJeNeqjC=s0-d)
Nelson BH et al. Curr. Opin. Immunol. 2015 Feb 21. 93-100
Nelson BH et al. Curr. Opin. Immunol. 2015 Feb 21. 93-100
Cancer genomics: why rare is valuable.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v3cIWXmdKNZcprEpZcaRt3r76_tygEW3QcbjbyD96VNB-BWM-jt6903EobvLmlakeCVbdPZqCtYhroAj5NPxafr5LZh4Iv84T2UT3ZbfaaCDhYoJeNeqjC=s0-d)
Jamshidi F et al. J. Mol. Med. 2015 Apr (4) 369-81
Jamshidi F et al. J. Mol. Med. 2015 Apr (4) 369-81
Association between genetic polymorphisms of inflammatory response genes and the risk of ovarian cancer.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v3cIWXmdKNZcprEpZcaRt3r76_tygEW3QcbjbyD96VNB-BWM-jt6903EobvLmlakeCVbdPZqCtYhroAj5NPxafr5LZh4Iv84T2UT3ZbfaaCDhYoJeNeqjC=s0-d)
Lu Zhi-Hui et al. J. Formos. Med. Assoc. 2015 Feb 3.
Lu Zhi-Hui et al. J. Formos. Med. Assoc. 2015 Feb 3.
Aberrant DNA damage response pathways may predict the outcome of platinum chemotherapy in ovarian cancer.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v3cIWXmdKNZcprEpZcaRt3r76_tygEW3QcbjbyD96VNB-BWM-jt6903EobvLmlakeCVbdPZqCtYhroAj5NPxafr5LZh4Iv84T2UT3ZbfaaCDhYoJeNeqjC=s0-d)
Stefanou DT et al. PLoS ONE 2015 (2) e0117654
Stefanou DT et al. PLoS ONE 2015 (2) e0117654
Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v3cIWXmdKNZcprEpZcaRt3r76_tygEW3QcbjbyD96VNB-BWM-jt6903EobvLmlakeCVbdPZqCtYhroAj5NPxafr5LZh4Iv84T2UT3ZbfaaCDhYoJeNeqjC=s0-d)
Minion LE et al. Gynecol. Oncol. 2015 Apr (1) 86-92
Minion LE et al. Gynecol. Oncol. 2015 Apr (1) 86-92
Epigenetic and genetic dispositions of ovarian carcinomas.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v3cIWXmdKNZcprEpZcaRt3r76_tygEW3QcbjbyD96VNB-BWM-jt6903EobvLmlakeCVbdPZqCtYhroAj5NPxafr5LZh4Iv84T2UT3ZbfaaCDhYoJeNeqjC=s0-d)
Yamaguchi K et al. Oncoscience 2014 (9) 574-9
Yamaguchi K et al. Oncoscience 2014 (9) 574-9
Identification of six new susceptibility loci for invasive epithelial ovarian cancer.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v3cIWXmdKNZcprEpZcaRt3r76_tygEW3QcbjbyD96VNB-BWM-jt6903EobvLmlakeCVbdPZqCtYhroAj5NPxafr5LZh4Iv84T2UT3ZbfaaCDhYoJeNeqjC=s0-d)
Kuchenbaecker KB et al. Nat. Genet. 2015 Feb (2) 164-71
Kuchenbaecker KB et al. Nat. Genet. 2015 Feb (2) 164-71
Ovarian Cancer: Recent Genomic Insights - January 20, 2015
Identification of six new susceptibility loci for invasive epithelial ovarian cancer![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v3cIWXmdKNZcprEpZcaRt3r76_tygEW3QcbjbyD96VNB-BWM-jt6903EobvLmlakeCVbdPZqCtYhroAj5NPxafr5LZh4Iv84T2UT3ZbfaaCDhYoJeNeqjC=s0-d)
Karoline B Kuchenbaecker et al. Nature Genetics, January 12, 2015
Karoline B Kuchenbaecker et al. Nature Genetics, January 12, 2015
Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v3cIWXmdKNZcprEpZcaRt3r76_tygEW3QcbjbyD96VNB-BWM-jt6903EobvLmlakeCVbdPZqCtYhroAj5NPxafr5LZh4Iv84T2UT3ZbfaaCDhYoJeNeqjC=s0-d)
Candido Dos Reis FJ, Clin Cancer Res. 2014 Nov 14
Candido Dos Reis FJ, Clin Cancer Res. 2014 Nov 14
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An ovarian tumour tissue analysis consortium study.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v3cIWXmdKNZcprEpZcaRt3r76_tygEW3QcbjbyD96VNB-BWM-jt6903EobvLmlakeCVbdPZqCtYhroAj5NPxafr5LZh4Iv84T2UT3ZbfaaCDhYoJeNeqjC=s0-d)
Köbel M, et al. Br J Cancer. 2014 Dec 9;111(12):2297-307
Köbel M, et al. Br J Cancer. 2014 Dec 9;111(12):2297-307
New strategies in ovarian cancer: translating the molecular complexity of ovarian cancer into treatment advances.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v3cIWXmdKNZcprEpZcaRt3r76_tygEW3QcbjbyD96VNB-BWM-jt6903EobvLmlakeCVbdPZqCtYhroAj5NPxafr5LZh4Iv84T2UT3ZbfaaCDhYoJeNeqjC=s0-d)
Liu J, et al. Clin Cancer Res. 2014 Oct 15;20(20):5150-6
Liu J, et al. Clin Cancer Res. 2014 Oct 15;20(20):5150-6
Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v3cIWXmdKNZcprEpZcaRt3r76_tygEW3QcbjbyD96VNB-BWM-jt6903EobvLmlakeCVbdPZqCtYhroAj5NPxafr5LZh4Iv84T2UT3ZbfaaCDhYoJeNeqjC=s0-d)
Emmanuel C, et al. Clin Cancer Res. 2014 Dec 15;20(24):6618-30.
Emmanuel C, et al. Clin Cancer Res. 2014 Dec 15;20(24):6618-30.
Knowledge-driven genomic interactions: an application in ovarian cancer.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v3cIWXmdKNZcprEpZcaRt3r76_tygEW3QcbjbyD96VNB-BWM-jt6903EobvLmlakeCVbdPZqCtYhroAj5NPxafr5LZh4Iv84T2UT3ZbfaaCDhYoJeNeqjC=s0-d)
Kim D, Li R, et al. BioData Min. 2014 Sep 9;7:20
Kim D, Li R, et al. BioData Min. 2014 Sep 9;7:20
Ovarian cancer biomarkers: current state and future implications from high-throughput technologies.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v3cIWXmdKNZcprEpZcaRt3r76_tygEW3QcbjbyD96VNB-BWM-jt6903EobvLmlakeCVbdPZqCtYhroAj5NPxafr5LZh4Iv84T2UT3ZbfaaCDhYoJeNeqjC=s0-d)
Leung F, et al. Adv Clin Chem. 2014;66:25-77.
Leung F, et al. Adv Clin Chem. 2014;66:25-77.
Ovarian Cancer Awareness: Genetics & Public Health - September 25, 2014
NCI information: Ovarian cancer: Prevention, genetics, causes![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_v3cIWXmdKNZcprEpZcaRt3r76_tygEW3QcbjbyD96VNB-BWM-jt6903EobvLmlakeCVbdPZqCtYhroAj5NPxafr5LZh4Iv84T2UT3ZbfaaCDhYoJeNeqjC=s0-d)
Did you know? >800 genes have been reported in relation to ovarian cancer risk and outcomes, including 21 genomewide association studies. To find out more, visit the HuGE Navigator
Find out which genetic conditions and tests are associated with ovarian cancer using the NIH Genetic Testing Registry
CDC fact sheet: Breast and ovarian cancer and family health history
No hay comentarios:
Publicar un comentario